MET and neoplasm: Based on our results, we hypothesize that tumor cells, driven by autocrine GAS6, activate the TAM‐RSK‐dependent survival pathway during the initial steps of tumorigenesis and secondarily switch to a proliferation mode by activation of the MET and/or EGFR‐dependent SRC‐AKT pathway.